News & Events
Working For Chroma
Site Designed & Maintained by The B&M Group
Chroma Therapeutics is focused on harnessing the power of chromatin biology and novel drug accumulation approaches to discover and develop a new generation of targeted cancer and inflammation treatments.
Click to view Chroma's Pipeline
Tosedostat Opal Study In Acute Myeloid Leukaemia Published In Lancet Oncology
Chroma Therapeutics Advances Novel Targeted Agent Towards Clinical Development; Receives Milestone Payment And Extends Collaboration With GSK